BioSyent

Toronto, Canada Founded: 2003 • Age: 23 yrs Listed
BioSyent is focused on developing innovative medicines for Canadians.

About BioSyent

BioSyent is a publicly listed company based in Toronto (Canada) founded in 2003. BioSyent is focused on developing innovative medicines for Canadians. It operates on a Reseller / Distribution model. The company has 60 employees. BioSyent has completed 1 acquisition, including Oralscience. BioSyent offers products and services including Innovative Medicines. Its focus areas include Pharmaceuticals and Specialty Pharmaceuticals. Its legal entity is BioSyent Inc.

Company details

BioSyent is engaged in sourcing, licensing, acquiring, and developing innovative pharmaceutical and healthcare products to address unmet medical needs in Canada and select international markets. The company is committed to improving patient lives through unique and effective solutions across various therapeutic areas. Operations are supported by a dedicated all-Canadian team, emphasizing integrity, respect, and leadership in the specialty pharmaceutical sector.

  • Headquarters Toronto, Canada
  • Employees 60
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website biosyent.com
  • Social LinkedIn YouTube
  • Legal Name Biosyent Inc.
Key Metrics
  • Annual Revenue
    $31.44 M (USD)
    22.9
    as on Dec 31, 2025
  • Net Profit
    $6.58 M (USD)
    23.96
    as on Dec 31, 2025
  • EBITDA
    $8.89 M (USD)
    31.89
    as on Dec 31, 2025
  • Employee Count
    60
  • Investments & Acquisitions

Products & Services of BioSyent

BioSyent offers a comprehensive portfolio of products and services, including Innovative Medicines.

Innovative Medicines
Pharmaceuticals

Innovative medicines are developed for Canadian healthcare needs.

Apps and channels of BioSyent

its YouTube channel BioSyent Pharma has 115 subscribers and 30 videos.

BioSyent Pharma
YouTube 115 subscribers 30 videos Autos & Vehicles
Open channel

Videos from BioSyent

The most watched videos on BioSyent's YouTube channel, BioSyent Pharma (115 subscribers). Click a video to play it here.

BioSyent named to 2024 TSX Venture Top 50
2.2K views
Q2/H1 Results Presentation 2023
1.8K views
Q3 Results Presentation 2023
331 views
BioSyent Inc Tibelia Asset Acquisition
324 views

More on BioSyent Pharma.

People of BioSyent

12 people are tracked at BioSyent (7 in leadership, 5 in team); the tracked headcount is 60.

NameRoleGroup
Maulik Patel
Director Of Business DevelopmentLeadership
Joost Van Der Mark
Vice President, Corporate DevelopmentLeadership
Kevin Wilson
Vice President, Community Business UnitLeadership
Ramesh Moothan
Director, International Business UnitLeadership
Rene C Goehrum
Chairman/President/CEOLeadership
Robert J. March
Vice President & Chief Financial OfficerLeadership
Ritu Kapoor
Director Of FinanceLeadership
Mohamed Makram
Business Development AnalystTeam
Jonathan Eccles
Accounting AnalystTeam
Sara Colman
Senior Marketing ManagerTeam
Joe Holloway
RepresentativeTeam
Jennifer Truong
Business Intelligence AnalystTeam
Premium access

Complete people profiles for BioSyent

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of BioSyent

BioSyent is a publicly listed company on the TSXV with ticker symbol RX in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date13 Jun 2006
  • Listed onTSX-V: RX
  • Listed entityBioSyent Inc.
  • Exchange sectorHealth technology
  • ISINCA0906901081
  • Share price15.97 CAD (-6.88% on the day) · 2026-10-13
  • Market capitalisation180,602,098.00 CAD
  • Price to earnings18.6
  • EPS (diluted, trailing year)0.86 CAD
  • Dividend yield1.35%
  • Volume (last session)27,732

Financials of BioSyent

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
202543.0M CAD9.0M CAD12.2M CAD
202435.0M CAD7.3M CAD9.2M CAD
202331.6M CAD6.5M CAD8.0M CAD
202227.9M CAD5.5M CAD7.4M CAD
202128.6M CAD6.3M CAD8.7M CAD
Premium access

Detailed financial statements for BioSyent

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by BioSyent

BioSyent has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Oralscience.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Offers dental care products, oral hygiene tools, and educational resources for health.
oralscience.com0Feb 2026••••
Premium access

Complete acquisition details for BioSyent

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of BioSyent

3 dated milestones of BioSyent across 23 years, from founding to its latest funding, stage changes and deals.

  1. Founded BioSyent is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Oralscience.

Web traffic of BioSyent

The website of BioSyent (biosyent.com) receives about 4.3K visits a month.

  • Monthly visits
    4.3K

    ▼ 3.4% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Biosyent

Premium access

Complete news archive for BioSyent

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BioSyent

BioSyent was founded in 2003.

BioSyent is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.

BioSyent has 60 employees.

Annual revenue of BioSyent is $31.44M as on Dec 31, 2025.

BioSyent is engaged in sourcing, licensing, acquiring, and developing innovative pharmaceutical and healthcare products to address unmet medical needs in Canada and select international markets. The company is committed to improving patient lives through unique and effective solutions across various therapeutic areas. Operations are supported by a dedicated all-Canadian team, emphasizing integrity, respect, and leadership in the specialty pharmaceutical sector.

BioSyent offers Innovative Medicines.

Yes, BioSyent is publicly traded on TSXV under the ticker symbol RX.

BioSyent has made 1 acquisition, including Oralscience.

BioSyent operates through Biosyent Inc..

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available